Dariusz Mariusz Koziorowski - Neurology

Author Information

Dariusz Mariusz Koziorowski is a distinguished researcher affiliated with the Department of Neurology at the Faculty of Health Science, Medical University of Warsaw, Poland. His research primarily focuses on neurological conditions with a particular emphasis on Parkinson's disease and related disorders. His work is recognized for its contribution to understanding the genetic and inflammatory aspects of these conditions.

Research Contributions

Dr. Koziorowski has made significant contributions to the field of neurology through his extensive research on Parkinson's disease, multiple system atrophy, and other movement disorders. His recent studies explore neuroinflammation patterns, the genetics of Parkinson's disease in specific populations, and the impact of cannabis from patient perspectives. Additionally, his research includes the study of diagnostic methods using imaging techniques like MRI and SPECT for differential diagnosis of neurological disorders.

Aliases

Throughout his academic career, Dariusz Mariusz Koziorowski has been referred to by several aliases, including D. Koziorowski, Dariusz Koziorowski, and Dariusz M. Koziorowski. These variations appear in different publications and databases.

Publication and Citation Metrics

Metric	Value
Citation Count	1446
H-index	19
Paper Count	145

Publications:

Platelet-to-lymphocyte ratio and neutrophil-tolymphocyte ratio may reflect differences in PD and MSA-P neuroinflammation patterns.

DOI: 10.5603/PJNNS.a2022.0014

Year: 2022

Anti-IgLON5 Disease – The Current State of Knowledge and Further Perspectives

DOI: 10.3389/fimmu.2022.852215

Year: 2022

Cannabis in Parkinson's Disease - the patient's perspective versus clinical trials: a systematic literature review.

DOI: 10.5603/PJNNS.a2022.0004

Year: 2022

The Strengths and Obstacles in the Differential Diagnosis of Progressive Supranuclear Palsy—Parkinsonism Predominant (PSP-P) and Multiple System Atrophy (MSA) Using Magnetic Resonance Imaging (MRI) and Perfusion Single Photon Emission Computed Tomography (SPECT)

DOI: 10.3390/diagnostics12020385

Year: 2022

Genetics of Parkinson's disease in the Polish population.

DOI: 10.5603/PJNNS.a2021.0013

Year: 2021

Movement disorders associated with chromosomal aberrations diagnosed in adult patients.

DOI: 10.5603/PJNNS.a2021.0038

Year: 2021

Soluble Urokinase Plasminogen Activator Receptor Levels Correlation with Other Inflammatory Factors in Prognosis of Disability and Death in Patients with Ischemic Stroke

DOI: 10.3390/brainsci12010039

Year: 2021

Patient with Parkinson’s disease and neuropathic pain – case report

DOI: 10.24292/01.mf.0321.15

Year: 2021

Frequency of mutations in PRKN, PINK1, and DJ1 in Patients With Early-Onset Parkinson Disease from neighboring countries in Central Europe.

DOI: 10.1016/j.parkreldis.2021.03.026

Year: 2021

Frequency of spinocerebellar ataxia mutations in patients with multiple system atrophy

DOI: 10.1007/s10286-020-00759-1

Year: 2021

What Are the Types of Multiple Sclerosis?

What are the Risks Involved?

What Role Does Genetics Play?

What are Common CNS Disorders?

What are Minimally Invasive Techniques?

What are common neurological disorders?

What is Neuropsychology?

How is Customizable Neurocare Implemented?

How Do Neuroprotective Drugs Work?

Why is Myelin Important?

Partnered Content Networks

Relevant Topics